The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proton Technologies

26 Sep 2023 07:00

RNS Number : 5869N
Sabien Technology Group PLC
26 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

26 September 2023

 

Sabien Technology Group plc

("Sabien", the "Company" or the "Group")

 

Proton Technologies

 

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, today announces that it has reviewed the value of its investment in Proton Technologies Canada Inc., ("Proton") following the proposed investment in and restructuring of Proton. 

 

On 14 October 2021, Sabien invested £100,000 in Proton, giving the Company a 0.08% shareholding. Subsequently, Sabien entered into a licensing agreement with Proton on 1 February 2022. This agreement allowed Sabien to deploy Proton's technology within the UK and the right to install a plant for the City Oil Field, Inc. plastic to oil technology on Proton's Saskatchewan site. Sabien retains the rights conferred by this licensing agreement.

 

On 8 September 2023, Proton informed its shareholders that it had received a proposal from a third party to inject new capital, restructure its balance sheet, and reform its management team (the "Proposal"). The Proposal remains subject to shareholder approval.

 

Following a review of the Proposal and ahead of approval by Proton shareholders, the Board of Sabien has concluded that the value of the Company's stake (£100,000) may require a material impairment provision in the accounts for the financial year to 30 June 2023. The Board expects that this provision will allow for a potential material diminution in the value of existing Proton equity to reflect the notional value of Proton ascribed by the Proposal. The level of provision will require agreement with the Company's auditors as part of the current audit process. Details of the provision, if any, will be provided in the Company's final results which are expected to be published in October 2023.

 

Richard Parris, Executive Chairman of Sabien, commented:

 

"While it is disappointing to provide for a possible short-term reduction in Proton's equity value, the Board is encouraged by the constructive details of the Proposal. It is clear that Proton requires a larger capital base from which to develop its leading hydrogen technology and we are supportive of the intention to re-balance the business. It remains to be seen as to the outcome of this Proposal, but Sabien is intent on a prudent approach to its balance sheet and the values contained within it."

 

For Further Information:

 

Sabien Technology Group plc

Richard Parris, Executive Chairman

Scott Fulton, Investor Relations 

 

 

 

+44 20 7993 3700

Scott.fulton@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDCCSDDGXU
Date   Source Headline
1st Jun 20107:00 amRNSTrading Statement
17th May 20107:00 amRNSChange of Adviser
1st Apr 201012:37 pmRNSGrant of options
25th Feb 20107:00 amRNSHalf Yearly Report
2nd Dec 20097:00 amRNSNew Contract Win
9th Nov 20097:00 amRNSAdjustment to number of warrants in issue
28th Oct 20097:00 amRNSPreliminary Results - 12 months ended 30 June 2009
14th Oct 20097:00 amRNSPlacing
7th Oct 20097:00 amRNSContract award
28th Sep 200911:40 amRNSAlliance Agreement with Jones Lang LaSalle
23rd Sep 20097:00 amRNSContract
7th Sep 20097:00 amRNSAlliance Agreement with Balfour Beatty
10th Aug 20097:00 amRNSAgreement with SERCO and British Gas
7th Aug 200911:32 amRNSLoan Agreement
27th Mar 20092:17 pmRNSHolding(s) in Company
27th Mar 20099:44 amRNSDirector/PDMR Shareholding
26th Mar 20097:00 amRNSOrder and UL certification
17th Mar 20096:14 pmRNSHolding(s) in Company
10th Mar 20094:21 pmRNSDirector/PDMR Shareholding
10th Mar 20097:00 amRNSDirector/PDMR Shareholding
9th Mar 20097:00 amRNSDirector/PDMR Shareholding
2nd Mar 20097:00 amRNSInterim Results
1st Oct 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSRe Contract
17th Sep 20087:00 amRNSHolding(s) in Company
4th Sep 20087:00 amRNSContract Win
19th Jun 20083:44 pmRNSStatement re share price move
14th Feb 20087:01 amRNSInterim Results
8th Jan 20087:01 amRNSChanges to Directors' Details
8th Jan 20087:00 amRNSChange of Adviser
28th Nov 200711:57 amRNSShare Purchase Sabien
16th Nov 20077:01 amRNSProposed Shares Purchase
13th Nov 20077:01 amRNSNew contract wins
12th Oct 20072:28 pmRNSDirector/PDMR Shareholding
4th Oct 200710:23 amRNSFinal Results
23rd Aug 200710:28 amRNSDirectorate Appointment
20th Aug 20074:07 pmRNSAIM RULE 26
1st Aug 20079:19 amRNSShare Sales & Trading Update
30th Jul 20072:12 pmRNSDirectorate Change
25th Jul 200712:26 pmRNSDirector/PDMR Shareholding
19th Jul 20077:00 amRNSDirector/PDMR Shareholding
26th Jun 20077:01 amRNSSabien Contract Win
1st Jun 200711:31 amRNSTrading Statement
24th May 20071:57 pmRNSEnergy White Paper
30th Mar 20077:04 amRNSInterim Results
25th Jan 20077:00 amRNSTrading Update
21st Dec 200610:45 amRNSTotal Voting Rights
20th Dec 20067:00 amRNSSabien First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.